Organ Transplantation | | Disease | Drug | Alemtuzumab (Campath)- FDA | | | | | | |
Arthritis | | Disease | Drug | Alemtuzumab (Campath)- FDA | | | | | | |
Anemia | | Disease | Drug | Alemtuzumab (Campath)- FDA | | | | | | |
Respiratory Tract Infections | | Disease | Drug | Alemtuzumab (Campath)- FDA | | | | | | |
Rheumatoid Arthritis | | Disease | Drug | Alemtuzumab (Campath)- FDA | | | | | | |
Cholesterol | | Disease | Drug | Kaempferitrin | | | | | | |
Hepatitis | | Disease | Drug | Alemtuzumab (Campath)- FDA | | | | | | |
Hepatitis | | Disease | Target | Maleylacetoacetate Isomerase | | | | | | |
Leukemias | | Disease | Drug | Alemtuzumab (Campath)- FDA | | | | | | |
Analgesia | | Disease | Target | Sodium Channel Nav1.8 | | | | | | |
Platelet Aggregation | | Disease | Target | Vascular Cell Adhesion Protein 1 | | | | | | |
Sedimentation Rate | | Disease | Target | Low-Density Lipoprotein Receptor-Related Protein 2 | | | | | | |
Obesity | | Disease | Target | Vascular Cell Adhesion Protein 1 | | | | | | |
Hearing Loss | | Disease | Target | Low-Density Lipoprotein Receptor-Related Protein 2 | | | | | | |
Osteoarthritis | | Disease | Target | Low-Density Lipoprotein Receptor-Related Protein 2 | | | | | | |
Glaucoma | | Disease | Target | Low-Density Lipoprotein Receptor-Related Protein 2 | | | | | | |
Stroke | | Disease | Target | Vascular Cell Adhesion Protein 1 | | | | | | |
Diabetic Nephropathy | | Disease | Target | Vascular Cell Adhesion Protein 1 | | | | | | |
Meningitis | | Disease | Drug | Amphotericin B (Fungizone)- FDA | | | | | | |
Seizure | | Disease | Target | Collapsin Response Mediator Protein-1 | | | | | | |
Diabetes | | Disease | Drug | Acamprosate Calcium (Campral)- FDA | | | | | | |
Chills | | Disease | Drug | Amphotericin B (Fungizone)- FDA | | | | | | |
Hearing Loss | | Disease | Target | Collapsin Response Mediator Protein-1 | | | | | | |
Depression | | Disease | Target | Collapsin Response Mediator Protein-1 | | | | | | |
Cancer | | Disease | Drug | Amphotericin B (Fungizone)- FDA | | | | | | |
Brain Injury | | Disease | Target | Collapsin Response Mediator Protein-1 | | | | | | |
Prostate Cancer | | Disease | Target | DNA-damage-inducible transcript 3 | | | | | | |
Tuberculosis | | Disease | Drug | Azathioprine (Imuran)- FDA | | | | | | |
Tuberculosis | | Disease | Drug | Amphotericin B (Fungizone)- FDA | | | | | | |
Hyperglycemia | | Disease | Target | DNA-damage-inducible transcript 3 | | | | | | |
Diarrhea | | Disease | Target | DNA-damage-inducible transcript 3 | | | | | | |
Infection | | Disease | Drug | Azathioprine (Imuran)- FDA | | | | | | |
Pneumonia | | Disease | Drug | Amphotericin B (Fungizone)- FDA | | | | | | |
Headache | | Disease | Drug | Amphotericin B (Fungizone)- FDA | | | | | | |
Dementia | | Disease | Target | DNA-damage-inducible transcript 3 | | | | | | |
Thrombocytopenia | | Disease | Drug | Alimta (Pemetrexed)- FDA | | | | | | |
Acne | | Disease | Drug | Alimta (Pemetrexed)- FDA | | | | | | |
Depression | | Disease | Drug | Atorvastatin Calcium (Lipitor)- FDA | | | | | | |
Cancer | | Disease | Drug | Atorvastatin Calcium (Lipitor)- FDA | | | | | | |
Cancer | | Disease | Drug | Amlodipine Besylate (Norvasc)- FDA | | | | | | |
Cancer | | Disease | Target | Squalene Monooxygenase | | | | | | |
Arrhythmia | | Disease | Drug | Amlodipine Besylate (Norvasc)- FDA | | | | | | |
Ovarian Cancer | | Disease | Drug | Alimta (Pemetrexed)- FDA | | | | | | |
Diarrhea | | Disease | Drug | Amlodipine Besylate (Norvasc)- FDA | | | | | | |
Stroke | | Disease | Drug | Atorvastatin Calcium (Lipitor)- FDA | | | | | | |
Lung Carcinoma | | Disease | Drug | Alimta (Pemetrexed)- FDA | | | | | | |
Renal Failure | | Disease | Drug | Alimta (Pemetrexed)- FDA | | | | | | |
Arthritis | | Disease | Drug | Amlodipine Besylate (Norvasc)- FDA | | | | | | |
Anemia | | Disease | Drug | Alimta (Pemetrexed)- FDA | | | | | | |
Benign Prostatic Hyperplasia | | Disease | Drug | Amlodipine Besylate (Norvasc)- FDA | | | | | | |
Rheumatoid Arthritis | | Disease | Drug | Amlodipine Besylate (Norvasc)- FDA | | | | | | |
Seborrhea | | Disease | Target | Epigen | | | | | | |
Colon Cancer | | Disease | Target | Epigen | | | | | | |
Skin Disease | | Disease | Target | Epigen | | | | | | |
Seizure | | Disease | Target | Epigen | | | | | | |
Cocaine Dependence | | Disease | Drug | Antabuse (Disulfiram)- FDA | | | | | | |
Psychiatric Disorder | | Disease | Drug | Antabuse (Disulfiram)- FDA | | | | | | |
Sedimentation Rate | | Disease | Target | Apo-SAA | | | | | | |
Drug Abuse | | Disease | Target | Epigen | | | | | | |
Carcinoma | | Disease | Target | DAPK2 | | | | | | |
Osteoarthritis | | Disease | Disease | Arthritis Juvenile | | | | | | |
Cancer | | Disease | Target | Apo-SAA | | | | | | |
Cancer | | Disease | Target | Exodus-2 | | | | | | |
Nausea | | Disease | Drug | Antabuse (Disulfiram)- FDA | | | | | | |
Fibromyalgia | | Disease | Disease | Arthritis Juvenile | | | | | | |
Anxiety | | Disease | Drug | Antabuse (Disulfiram)- FDA | | | | | | |
Anxiety | | Disease | Drug | Alosetron Hydrochloride (Lotronex)- FDA | | | | | | |
Hypertriglyceridemia | | Disease | Target | Apo-SAA | | | | | | |
Tuberculosis | | Disease | Disease | Arthritis Juvenile | | | | | | |
Infection | | Disease | Drug | Antabuse (Disulfiram)- FDA | | | | | | |
Infection | | Disease | Target | Apo-SAA | | | | | | |
Schizophrenia | | Disease | Drug | Antabuse (Disulfiram)- FDA | | | | | | |
Stroke | | Disease | Target | Exodus-2 | | | | | | |
Osteoporosis | | Disease | Disease | Arthritis Juvenile | | | | | | |
Glomerulonephritis | | Disease | Target | Apo-SAA | | | | | | |
Shock | | Disease | Target | Apo-SAA | | | | | | |
Joint Pain | | Disease | Disease | Arthritis Juvenile | | | | | | |
Celiac Disease | | Disease | Disease | Arthritis Juvenile | | | | | | |
Sarcoidosis | | Disease | Disease | Arthritis Juvenile | | | | | | |
Platelet Aggregation | | Disease | Drug | Alprostadil (Prostin VR Pediatric)- FDA | | | | | | |
Skin Disease | | Disease | Target | Eotaxin-3/CCL26 | | | | | | |
Diabetes | | Disease | Target | CEBP alpha | | | | | | |
Diabetes | | Disease | Drug | Alprostadil (Prostin VR Pediatric)- FDA | | | | | | |
Thromboembolism | | Disease | Drug | Alprostadil (Prostin VR Pediatric)- FDA | | | | | | |
Obesity | | Disease | Drug | Alprostadil (Prostin VR Pediatric)- FDA | | | | | | |
Carcinoma | | Disease | Target | AURKC | | | | | | |
Cervical Cancer | | Disease | Target | AURKC | | | | | | |
Hemorrhage | | Disease | Drug | Alprostadil (Prostin VR Pediatric)- FDA | | | | | | |
Fracture | | Disease | Target | CEBP alpha | | | | | | |
Prostate Cancer | | Disease | Drug | Alprostadil (Prostin VR Pediatric)- FDA | | | | | | |
Inflammatory Bowel Disease | | Disease | Target | Eotaxin-3/CCL26 | | | | | | |
Infection | | Disease | Target | Eotaxin-3/CCL26 | | | | | | |
Infection | | Disease | Target | CEBP alpha | | | | | | |
Kidney Diseases | | Disease | Target | BD4 | | | | | | |
Hepatitis B | | Disease | Disease | Transplant Bone Marrow | | | | | | |
Stroke | | Disease | Drug | Alprostadil (Prostin VR Pediatric)- FDA | | | | | | |
Dyspnea | | Disease | Drug | Alprostadil (Prostin VR Pediatric)- FDA | | | | | | |
Aspergillosis | | Disease | Disease | Transplant Bone Marrow | | | | | | |
Gastroesophageal Reflux Disease | | Disease | Target | AURKC | | | | | | |
Osteoporosis | | Disease | Drug | Alprostadil (Prostin VR Pediatric)- FDA | | | | | | |